throbber

`
`
`Journal of
`
`
`
`
`Clinical Pharmacy
`1. nd Therapeutics
`
`
`
`ALCON 2123
`
`Argentum Pharm. LLC V. Alcon Research, Ltd.
`Case IPR2017-01053
`
`

`

`Journal of Clinical Pharmacy and Therapeutics
`
`EDITORS
`A. Li Wan Po and M. J. Kendall
`
`ASSOCIATE EDITOR
`D. B.Jack
`
`EDITORIAL BOARD
`M. C. Allwood
`P. Amacker
`R. A. Anderson
`C. W. Barrett
`Joaquin Ronda Beltran
`H. Bundgaard
`Win L. Chiou
`T. D. Clarke
`A. M. S. Cullen
`
`TECHNICAL EDITOR
`S. E. Tibbetts
`
`P. F. D'Arcy
`S. S. Davis
`A. F. Fell
`C. Hetherington
`C. R. Hitchings
`J. H. Kilwein
`E. van der Klein
`E.J. Lien
`P. Lundgren
`
`A. Main
`B. Mulley
`T. Nagai
`Mogens Nedergaard
`C. J. Rolles
`D. Schaaf
`R. G. Shanks
`A. Wertheimer
`J. Wikstrand
`D. Worthen
`
`is designed to provide a forum for clinicians.
`This journal
`pharmacists and other health professionals to explore and report on
`areas of common interest in pharmacy, therapeutics and clinical
`pharmacology. lts scope embraces all aspects of drug development
`and drug use. Reports and commentaries on current issues in medical
`and pharmaceutical practice are also encouraged.
`
`SUBSCRIPTION INFORMATION. Journal of Clinical Pharmacy and
`Therapeutics is published bimonthly and the subscription price for
`1992 is £160.00 (U.K.), £168.00 (overseas), $285.00 (North
`America and Canada) post free. The journal is despatched within
`Europe by surface mail. to other continents by various forms of air
`speeded delivery, to the U.S. (Second Class postage paid at Rahway,
`NJ. Postmaster, send address corrections to Journal of Clinical
`Pharmacy and Therapeutics Mercury Airfreight International Ltd.,
`2323 EF Randolph Avenue, Avenel, NJ 07001 (US Mailing Agent),
`U.S.A.) by air freight for forwarding by second class post, to India by
`air freight for guaranteed local delivery, and to all other countries by
`accelerated surface post.
`All correspondence relating to subscriptions and back numbers
`should be sent to the Journal Subscriptions Department, Marston
`Book Services, P.O . Box 87, Oxford, UK. Tel: + 44 (865) 791155 .
`Fax: + 44 (865) 791 927.
`
`ADVERTISIN G. Enquiries and booki ngs for advertisements sho uld
`be sent to the Advertisement Manager, Blackwell Scientifi c Publi(cid:173)
`cations Ltd, Osney Mead, O xford OX2 OEL. Tel: + 44 (865) 240201,
`Fax No. +44 (865) 721205, Telex 83355 Medbok G .
`
`© 1992 Blackwell Scientific Publications Ltd. Authorization to pho (cid:173)
`tocopy items for internal or personal use, or the internal o r personal
`use of specific clients. is g ranted by Blackwell Scientific Publicatio ns
`Ltd for libraries and other users registered wi th the Copyright Clear(cid:173)
`ance Center (CCC) T ransactional Reporting Service, provided that
`the base fee of $06.00 per copy is paid directly to CCC. 27 Co ngress
`Street, Salem, MA 01970, U.S.A. The consent d oes not extend to
`other kinds of copying, such as copying for gene ral distribution for
`advertising or promotional purposes, for creating new collective
`works for resale. Special requests should be addressed to the Ed itor.
`0269-4 72 7 / 92 $06.00.
`
`This journal is covered by Current Contents, A SCA. ISIIBJOMED,
`Science Citation Index and ADONIS.
`
`Journal of Clinical Phannacy and Therapeutics is printed o n acid-free
`paper.
`
`Printed in Great Britain by Henry Ling Limited, The Dorset Press, Dorchester, Dorset
`
`

`

`Journal of Clinical Pharmacy and Therapeutics (1992) 1 7, 51-54
`
`The antimicrobial action of zinc ion/ antioxidant combinations
`T. J. McCarthy, J. J. Zeelie* and D. J. Krause
`Pharmacy Department, University of Port Elizabeth, PO Box 1600 and• Pharmacy Department, PE Technikon, Private Bag
`X601 1, Port Elizabeth 6000, South Africa
`
`SUMMA RY
`
`The potentiation of action of antimicrobial
`preservatives/antiseptics by, respectively, anti(cid:173)
`oxidants and metal ions has been established. In
`this investigation the antimicrobial effect of two
`antioxidants
`(Buty lated hydroxyanisole
`and
`Propyl Gallate) and zinc ions, both separately
`and combined, was determine d against three or(cid:173)
`g anisms at 37°C. With the exception of Escheri(cid:173)
`chia coli at low zinc concentrations, definite
`potentiation occurred, as re flected by a decrease
`in killing times.
`
`INTRODUCT IO N
`
`The fields of disinfection, antisepsis, and preservation
`are closely related. Before the plethora of antimicrobial
`agents became available it was a valid assertion to state
`that phenol, at concentrations of 3, 1 and 0·5% m/ v,
`respectively, could classify as a disinfectant, antiseptic
`and a preservative. Today we have over 100 preserva(cid:173)
`tives alone, each with its own spectrum of antimicrobial
`activity and its own inherent problems.
`Over the last decade there has been an increasing
`tendency to employ combinations of such antimicrobial
`agents, both to broaden the spectrum of activity (Gram(cid:173)
`positive/ Gram-negative/ fungal) and to di scourage the
`emergence of adaptive resistance. There has also been a
`move away from potent synthetic chemical structures
`to consumer friendly or natural prod ucts.
`Our previous work has centred on t he antimicrobial
`action of combinations of selected preservatives and
`antioxidants (1), and on combinations of selected preser(cid:173)
`vatives. antiseptics and metal ions (2, 3). Here we report
`on combinations of zinc ions and two antioxidants
`(Butylated hydroxyanisole and Propyl gallate). These
`have been examined as preservatives (as all three may
`be orally ingested) and as potential topical deodorants/
`antiseptics. It is the latter aspect which is reported
`here.
`
`MATERIALS AND METHODS
`
`Materials
`
`The following materials were used in this study. Zinc
`sulphate (ZnS04.7H 20) as a source of zN2+ ions;
`butylated hydroxyanisole (BHA), (2- and 3-tert-butyl-
`4-methoxy phenol); propyl gallate (PG), (propyl-3,4,5-
`trihydroxygenzoate); sodium chloride; and ethanol. All
`materials were from reputable suppliers.
`
`Media
`
`Tryptone Soy Broth was used as the recovery medium,
`followed by 24-h incubation at 37°C.
`
`Micro-org anisms
`
`Each system was separately challenged with an over(cid:173)
`night culture of the following, suitably diluted after
`reading
`the absorbance at 600 nm to give a final
`I x 106 cells/ ml final test solution.
`concentration of -
`The following micro-organisms were used: Escherichia
`coli (NCTC 10418), Staphylococcus aureus (NCTC 6571),
`Candida albicans (patient isolate).
`
`M ethods
`
`Ethanolic solutions of BHA and PG were prepared and
`through sterile 0·22 µM filters. A ll other
`sterilized
`ingredients were sterilized by autoclaving at 116°C for
`30 min. Suitable dilutions of z n2+, BHA and PG were
`made into normal saline containing a final calculated con(cid:173)
`centration of ethanol. 4% v/ v, to keep the poorly soluble
`antioxidants in solution. All work was performed in dupli(cid:173)
`cate under a horizontal laminar airAow cabinet.
`
`Contact killing time determinations
`
`Prepared inoculated solutions were kept at 37°C and
`samples (O·l ml) were transferred via sterile pipette
`
`51
`
`

`

`52 T.]. McCartliy et al.
`
`Micro-organism
`
`zni+
`(µg/ml)
`
`1
`
`5
`
`10
`
`16
`
`18
`
`24
`
`48
`
`Time(h)
`
`Table 1. Contact killing times at
`37°C of zinc ions against three micro-
`organisms in normal saline containing
`4%ethanol
`
`$. QIIWIS
`
`E.coli
`
`C. albicans
`
`5
`10
`50
`
`5
`10
`50
`
`5
`10
`50
`
`+ + + + + + +
`+ + + + + + +
`+
`+ + + + + + +
`+ + + + + + +
`+ + + +
`+ + + + + + +
`+ + + + + + +
`+ +
`
`+ = Growth, - = no growth.
`
`Micro-organism
`
`Concentration (%)
`BHA
`
`180 230 250 270 340 360
`
`Time (min)
`
`Table 2. Contact killing times at
`37°C of butylated hydroxyanisole
`against three micro-organisms in
`normal saline containing 4% ethanol
`
`5. aum15
`
`E.coli
`
`C. albicans
`
`0·038
`0·040
`
`0·038
`0·040
`
`0·038
`0·040
`
`+ +
`
`+
`
`+ +
`+ +
`+ +
`+
`
`+
`
`+ +
`
`+
`
`+
`
`tips to 2 ml volumes of T ryptone Soy Broth in sterile
`containers, followed by incubation for 24 h at 37°C.
`(Tables 1-4).
`
`Dilution coefficient (TJ values) determinations
`
`The 17 values for the antioxidants were determined
`(Table 5) using the following formula:
`
`where C, and C2 are the first and second concentrations
`of the test substance; and t 1 and 12 are the killing times of
`cl and cl' respectively.
`
`+ = Growth. - = no growth.
`
`RES UL TS AND D ISCUSS ION
`
`It can be seen from Table I that zn2+ ions have
`little effect on microbials except at a concentration of
`50 µg/ ml. The same effect has been observed for
`Minimum Inhibitory Concentrations (MIC) when used
`alone (2). Furthermore, zn2+ ions have little effect
`against the troublesome Pseudomonas aeruginosa. Tables
`2 and 3, respectively, reflect the killing times of low
`concentrations of BHA and PG. Although these killing
`times would be considered as satisfactory and even
`desirable in topical cosmetic and pharmaceutical formu(cid:173)
`lations, they would not be considered adequate in a
`clinical situation as a topical antiseptic. Combinations of
`zn2+ ions with each of the antioxidants has, however,
`shown promising potentiation for S. aureus and C.
`
`

`

`Table 3. Contact killing times at
`3 7°C of propyl gall ate against three
`micro-organisms in normal saline
`containing 4% ethanol
`
`Micro-organism
`
`Concentration
`(pg)
`
`130 190 220 240 310 330
`
`Time(min)
`
`Antimicrobial action of zinc ion 53
`
`S. aureus
`
`E.coli
`
`C. albicans
`
`0·19
`0.20
`
`0·19
`0.20
`
`0·19
`0·20
`
`+ + + +
`+ +
`+
`
`+ + + + +
`+ + +
`
`+ = Growth, - = no growth.
`
`Table 4. Effect at 37°C of added zinc ions on the contact
`killing times of 0·04% butylated hydroxyanisole and 0·2%
`propyl gallate against three micro-organisms in normal saline
`containing 4% ethanol
`
`Micro-organism
`
`Added Znz+
`(µg/ ml)
`
`BHA
`
`PG
`
`S. aureus
`
`E. coli
`
`C. albicans
`
`0
`5
`10
`50
`
`0
`5
`10
`so
`0
`5
`10
`so
`
`180
`70-90
`60-70
`20- 30
`
`220
`130
`80-90
`50
`
`250
`250-270
`300
`160-170
`
`130
`150
`150-170
`60-80
`
`230
`15
`9
`6
`
`240
`160
`130
`60-80
`
`Table 5. A summary of the I'/ values at 37°C for butylated
`hydroxyanisole and propyl gallate against three micro(cid:173)
`organisms in normal saline containing 4% ethanol
`
`Micro-organism
`
`S. aureus
`E.coli
`C. albicans
`
`BHA
`
`7·7
`7·3
`7-7
`
`PG
`
`7·1
`8·1
`6·7
`
`albicans. With the latter the addition of only 10 µg / ml
`of z n2+ ions to 0·04% BHA reduced the killing time
`from 230 to 9 min (T able 4). Propyl gallate in general is
`less active than BHA but enhanced activity is observed
`when z n2+ ions are added. In the case of E. coli Table 4
`shows that with only 50 µ g/ ml an improved killing time
`is observed for both BHA and PG, with 5 and 10 µg/ ml
`actually delaying the killing time. Isobolograms plotted
`for the minimum lethal concentrations of Znz+ ions and
`BHA or PG, respectively, showed defin ite antagonism
`for BHA and slight antagonism between the median
`range of Znz+ ions and PG against E. coli.
`Table 5 shows that the antioxidants possess high r,
`values. As shown by the formula C'1 x f = k, an increase
`in concentration of an antimicrobial with a high r, value
`can dramatically reduce the killing time. For example, if
`phenol (r, = 6) at 1% concentration kills an inoculum in
`100 min, then doubling the concentration should reduce
`the killing time to 1·56 min (100/26). If the phenol should
`be decreased to 0·5% by complexation however, (sorp(cid:173)
`tion into plastic or rubber, volatization, etc), then the
`killing time lengthens to 4·5 days: (!6 x 106(h) = 100).
`This can give rise to contaminated products, nosocomial
`infections and adaptive resistance. Fortunately the
`QACs have r, values of 1, and chlorhexidine has an r,
`value of 2 so that dilution will not profoundly affect
`these classes of antimicrobial agents. We have pre(cid:173)
`viously determined brono pol and germall II as having
`values of 0·92 and 0·96, respectively, against E. coli (4),
`and benzoic acid as 1·75, however, the aromatic alcohols
`benzyl alcohol and phenethyl alcohol gave figures of 7
`and 9, respectively (4), so that the compounds, along
`w ith the phenolics, need to be carefully monitored fo r
`inactivation/ dilution effects.
`
`

`

`54
`
`T. ]. McCarthy et al.
`
`This preliminary work indicates potentially useful
`synergism between the consumer friendly antioxidants
`BHA and PG and zn2+ ions at low levels suitable
`for foodstuffs and oral pharmaceuticals. At
`the
`concentrations employed here, however, the killing rate
`does not indicate any beneficial clinical advantage over
`existing preparations combined with z n2+ ions at levels
`below 50 µg/ ml.
`
`REFERENC ES
`
`I. Zeelie JJ. McCarthy TJ. (1985) The antimicrobial activities
`of selected preservatives in the presence of phenolic
`
`antioxidants. South African Pharmacy journal, 52(4),
`161-163.
`2. McCarthy TJ. (1985) Metal ions as microbial inhibitors.
`Cosmetics and Toiletries, 100, 69-72.
`3. McCarthy TJ, Zeelie )J. (1989) The effect of zinc ions on
`antimicrobial activity of selected preservatives. Journal of
`Pharmacy and Pharmacology, 4 IS, 114P.
`4. Hurwitz SJ, McCarthy TJ. (1986) 2, 3, 5-Triphenyltetra(cid:173)
`zolium chloride as a novel tool in germicide dynamics.
`journal of Pharmaceutical Sciences, 75, 912- 916.
`5. Hurwitz SJ. McCarthy TJ. (1987) The effect of pH and
`concentration on the rated of kill of benzoic acid solutions
`against E. coli. journal of Clinical Pharmacy and Therapeutics,
`12, 107- 115.
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket